Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-25-001778)

Filing Details

Accession Number:: 0001225208-25-001778
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-14 17:16:36
Reporting Period:: 2025-02-13

Filing Date:: 2025-02-14
Accepted Time:: 2025-02-14 17:16:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1214686	E Ronald Blaylock	66 Hudson Boulevard East Attn: Corporate Secretary New York NY 10001-2192		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-02-13	19,457	$25.65	27,707	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,750	Indirect	By Trust